Pancreatic Cancer Trial, Recruiting NCT07561814 Sponsor: Shanghai Zhongshan Hospital Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT07561814
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years old or older.
  • You must have been diagnosed with pancreatic cancer, confirmed through a tissue or cell sample test.
  • Your medical records at the participating hospital must include CT scan images taken before and after surgery, along with related medical information, pathology reports, and blood test results from around the time of surgery.
  • You must have had surgery for pancreatic cancer at one of the hospitals taking part in this study.

Who may not be able to join:

  • People under 18 years of age cannot take part.
  • People with other serious health conditions — such as severe liver or kidney problems, serious heart or brain conditions, or a cancer other than pancreatic cancer — may not be eligible.
  • Women who are pregnant or breastfeeding may not be able to join.
  • People with a mental illness may not be eligible.
  • People who are unable to attend follow-up appointments or who cannot give their formal agreement to take part may not be eligible.
  • People whose medical records contain unusual test results that cannot be medically explained, or whose records have too much missing information, may not be eligible (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
9 December 2025
Est. completion
31 July 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

overall survival; recurrence free survival; recurrence status within one year after surgery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov